US Defence Secretary Mark Esper on Friday ruled out allegations of unfair competition in the awarding of a US$10-billion cloud computing contract to Microsoft.
“I am confident it was conducted freely and fairly, without any type of outside influence,” Esper told a news conference in Seoul, South Korea.
Formally called the Joint Enterprise Defence Infrastructure, or JEDI, the contract was awarded to Microsoft on 25 October, and the lucrative deal could span 10 years.
There are many directions we could go when it comes to the future of sustainable energy—but the UK made a bold move when it announced a huge investment (220 million pounds huge) in a prototype fusion power facility that could be functioning as a commercial power plant by 2040.
So it’s safe to say the race to fusion power is on. Fusion energy could provide us with clean, basically limitless energy.
But the thing is, fusion power isn’t really a reality yet, but does this prototype facility have a shot at making fusion a reality?
Nuclear fusion is what powers stars, including the sun. The ‘fusion’ part refers to the fact that isotopes of extremely light elements like hydrogen, are fusing together at the extremely high temperatures and pressures that exist at the center of stars. Under these conditions, gases like helium and hydrogen actually exist as plasmas.
So how could we possibly recreate what happens inside of stars here on Earth? By replicating those extreme conditions so that we can get the atoms to behave the way we want them to.
When gigantic stars run out of fuel they collapse under their own gravity and, in a last hurrah, send out a blast of light and matter in the most violent known explosions in the universe.
Now astronomers have discovered that these cataclysmic events, known as gamma ray bursts, release roughly twice as much energy as previously thought.
The rethink comes after an international team registered a record-breaking observation of the highest-energy radiation ever measured from gamma ray bursts.
Barbara Liskov pioneered the modern approach to writing code. She warns that the challenges facing computer science today can’t be overcome with good design alone.
A University of Miami doctor says he can rebuild a whole jaw using new stem cell collection technology.
Known as the “MarrowMarxman”, the FDA-registered device was developed and tested by Dr. Robert Marx, who is a professor and chief of the Division of Oral and Maxillofacial Surgery at the University of Miami Miller School of Medicine.
…Hope4Cancer Treatment Centers™ announces Eight Days, a groundbreaking reality TV series that tells the stories of five cancer patients and their journey using alternative cancer treatments that are working. The first reality TV series of its kind, Eight Days, is set to premiere on the FYI Television Network on January 4, 2020 and will give viewers an inside look at what healing from cancer is really like, as well as highlight new integrative cancer treatment options.
Everyone is getting excited to watch this life-changing series! For more information about 8 Days visit our website at https://hope4cancer.com/8-days-season-2/.
Nanoracks wants to expand from hosting experiments on board the International Space Station to running their own mini stations built from used rockets, with a first launch scheduled for a SpaceX Falcon 9 next year.
The process of rifting in Africa means that the continent is slowly breaking apart and with that comes lots of volcanoes, some with the potential for massive explosive eruptions.
Promising preliminary data from one of the first human trials testing the safety and efficacy of a CRISPR gene therapy has just been revealed. Although it is too early to evaluate long-term effects, the initial reports are impressively successful for two patients with severe genetic blood diseases.
Until February of this year, when pharmaceutical companies CRISPR Therapeutics and Vertex began a large global trial into a treatment called CTX001, no human outside of China had been officially treated with a CRISPR-based gene editing therapy.
CTX001 was developed to treat two types of inherited blood disease, beta-thalassemia and sickle cell disease. Both conditions are caused by a mutation in a single gene and the treatment involves engineering a patient’s stem cells with a single genetic change designed to raise levels of fetal hemoglobin in red blood cells.
“This inverse association was robust, consistently seen across current, past, and never smokers, as well as men, women, and individuals with different backgrounds,” she adds.
Shu says the health benefits may be rooted in their prebiotic (nondigestible food that promotes growth of beneficial microorganisms in the intestines) and probiotic properties. The properties may independently or synergistically modulate gut microbiota in a beneficial way.
The research appears in JAMA Oncology. Additional coauthors are from Seoul National University and Vanderbilt.